Intellia Therapeutics, Inc. (NTLA)

9.55 +0.18 (+1.92%) USD  |  NASDAQ  |  Dec 11, 16:00
9.46 -0.09 (-0.94%) After-Hours: 06:35
More

Intellia Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Pacific Biosciences of California, Inc. Upgrade